Search results for: 'tools supporting cell ad gene therapy market'
- Did you mean
- tools supporting cell ad g01e therapy market
- Related search terms
- marketing strategy hotel industry year 1999
- cell biolog research market global 2014 2020
- marketing strategy homes industry year 16.9
- marketing strateg homes industry year 1.09
- market analyst of rf energy harvesting technolog
-
18 Oct 2024  |  Global  |  Market Research
Image-guided Therapy Market, Global, 2024-2029
Increased Demand for Minimally Invasive Procedures and the Surge in Day Surgeries at Outpatient Facilities are Driving Transformational Growth
The image-guided therapy (IGT) market is growing rapidly, mainly driven by the rising preference for minimally invasive procedures, technological advancements in multimodal imaging, artificial intelligence, the use of software solutions that enable better clinical outcomes, and the high demand for precision medicine in oncology treatment. In additi...
$4,950.00
Special Price $4,207.50 save 15 %
-
06 Aug 2026  |  Global  |  Market Research
Machine Tools Sector, Global, 2023–2030
The Shift to High-precision and Multi-functional Machines is Driving Transformational Growth
This study provides an in-depth understanding of the machine tools industry. It discusses the key trends and challenges faced by machine tool manufacturers, in addition to providing forecasts until 2030. The study provides a region-wise breakdown with discussions on key industries. Machine tool manufacturing is being reshaped by a combination of di...
$4,950.00 -
11 Mar 2019  |  North America  |  Market Research
Global Cell Therapy Market—Companies to Action, 2018
A Collaborative Business Model With Focus on Stem Cells, Chimeric Antigen Receptor T (CAR-T) Cells and Combination Therapies Will Propel Market Growth
The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...
$3,000.00
Special Price $2,250.00 save 25 %
-
28 Sep 2018  |  North America  |  Technology Research
Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Oct 2018  |  North America  |  Market Research
Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025
A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market
The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Feb 2024  |  Global  |  Market Research
Innovation Waves in Immuno-oncology Therapy Development
Next-gen Cell Therapies and Precision Immunotherapies are Driving Growth and New Product Development
Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Nov 2023  |  Global  |  Market Research
Single-cell Analysis: Technology Growth Opportunities
Technological advancements in single-cell analysis propel new diagnostic and therapeutic opportunities.
Single-cell analysis can diagnose a condition in heterogenous cell population samples by studying genomics, transcriptomics, proteomics, metabolomics, and other cellular interactions in cells. It helps to understand a tumor microenvironment better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provide...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Nov 2023  |  Global  |  Market Research
Global Machine Tool Measurement Growth Opportunities
Precision Machining will Continue to Drive the Future Growth Potential of Machine Tool Measurement
This Frost & Sullivan research service offers a detailed analysis of the machine tool measurement (MTM) market. The MTM market is mature, with machine tool original equipment manufacturers (OEMs) contributing to a large portion of the demand. Despite the current economic uncertainty, growing automation across industries will play a key role in driv...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 May 2023  |  Global  |  Market Research
Stationary Fuel Cell Growth Opportunities
Huge Levels of Global Investment in the Hydrogen Economy will be Key to Taking the Sector and the Technology to the Next Level
Energy decentralization, supportive regulations and policies, greater focus on sustainability, and the crucial development of a hydrogen economy will drive stationary fuel cell industry growth during the next decade. The wider market for decentralized energy solutions is thriving as residential, commercial, and industrial customers look to achieve ...
$4,000.00
Special Price $3,000.00 save 25 %
-
16 Nov 2022  |  North America  |  Frost Radar
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022
A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines
As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...
$4,950.00
Special Price $3,712.50 save 25 %